Status:
COMPLETED
Biomarkers of Cardiovascular Complications in Chronic Kidney Disease
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Chronic Renal Disease
Eligibility:
All Genders
18+ years
Brief Summary
Identification of new retention solutes associated with cardiovascular (CV) toxicity in Chronic Kidney Disease (CKD) patients will help to better understand the pathophysiological mechanisms at stake ...
Eligibility Criteria
Inclusion
- patient with stage 4 or 5 CKD.
Exclusion
- patient with stage 1, 2 or 3 CKD
- patient with solid tumor
- patient with malignant blood disease
- patient with acute kidney disease in the past 3 months
- patient with acute glomerulonephritis in the past 6 months.
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT03274921
Start Date
September 1 2017
End Date
June 30 2020
Last Update
July 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Toulouse
Toulouse, France, 31059